Informa
TIDES USA: Oligonucleotide & Peptide Therapeutics
2025³â 5¿ù 19-22ÀÏ
Manchester Grand Hyatt San Diego, CA, USA
Key Sessions
Kristy Wood, PhD
Realizing the Promise of CRISPR Therapeutics
Intellia Therapeutics
Hiroaki Suga, PhD
RaPID Display and Selection of Pseudo-natural Products
University of Tokyo
Art Levin, PhD
State of the Art: A Look at Oligonucleotide Therapeutics Past, Present, and Future
Avidity Biosciences
Lotte Bjerre Knudsen, PhD
The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook
Novo Nordisk A/S
Muthiah (Mano) Manoharan, PhD
¡°I Love Conjugates¡±: The GalNAc Revolution and Its Impact on Oligonucleotide Therapeutic Development
Alnylam Pharmaceuticals
Sam Tsimikas, MD
Clinical Update on Oligonucleotides for Cardiovascular Disease
Ionis Pharmaceuticals